Xinhua Luo

Dr. Xinhua Luo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
XLXinyue Li
Xinyue Li
ZSZexuan Song
Zexuan Song
JLJinshuo Liu
Jinshuo Liu
JJJingguang Jin
Jingguang Jin
HWHanxia Wan
Hanxia Wan
XLXinhua Luo
Xinhua Luo
This study isolated a Klebsiella pasteurii strain, K1134, from the sputum of an ICU patient, revealing its resistance to the carbapenem antibiotics meropenem and imipenem. Whole-genome sequencing identified a plasmid pK1134-KPC, which carries the carbapenem resistance gene blaKPC-2. pK1134-KPC, belonging to the IncFIIpCP020359 plasmid group, exhibits a modular structure with blaKPC-2 embedded in a 32.09 kb accessory region containing multiple accessory genetic elements (AGEs). Comparative genomic analysis of 48 K. pasteurii isolates from 12 countries showed high genetic diversity, with strains clustered into three clades. Notably, K. pasteurii harbors extensive antimicrobial resistance genes across diverse AGEs, classifying it as multidrug-resistant. Twelve blaKPC-carrying AGEs were identified from the sequences of the isolates, classified into two groups: Tn7551 and Tn6296-related elements. The gene clusters for enterotoxins tilimycin and tilivalline, encompassing key regulators and operons, were present in nearly all strains, with incomplete clusters exclusively observed in clade 3 isolates. This study underscores the global dissemination and genetic adaptability of K. pasteurii, highlighting its potential role as a reservoir for resistance genes and emphasizing the need for robust surveillance to mitigate its public health impact.

14 November 2024 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
JFJiao Feng
Jiao Feng
ZSZhiwei Song
Zhiwei Song
PDPiaopiao Dai
Piaopiao Dai
HCHuimin Chen
Huimin Chen
DHDakang Hu
Dakang Hu
XLXinhua Luo
Xinhua Luo
Background: Carbapenem-resistant Enterobacter cloacae (CR-ECC) complex has posed significant challenges to the clinical treatment of infections, and Enterobacter hormaechei ( E. hormaechei) is the most commonly identified nosocomial pathogen of CR-ECC. Methods: Carbapenemases were detected by the immunocolloidal gold technique. The minimum inhibitory concentration (MIC) values were determined by VITEK2. The genome sequence of strain K432 was obtained and analysed. Results: We isolated the IMP-8-producing E. hormaechei strain K432 from a patient's urine specimen in a Chinese hospital, which exhibited resistance to multiple antibiotics, including ceftazidime, piperacillin/tazobactam, aztreonam, imipenem, meropenem, ciprofloxacin, levofloxacin, minocycline, and trimethoprim/sulfamethoxazole. The genome of strain K432 was composed of the chromosome cK432 (4863 kb) and 3 plasmids: pK432-IMP (45.8 kb), pK432-TEM (75.6 kb), and pK432-NR (4.8 kb). In K432, six drug-resistant genes were detected, including bla ACT-7 and fosA on cK432, bla IMP-8 , and qnrS1 on pK432IMP, bla SFO-1 , and bla TEM-1 on pK432-TEM. The pK432-IMP belonged to a novel incompatibility group, and pK432-TEM was an incompatibility (Inc) R plasmid. Both of these two plasmids shared similar conserved backbone regions with their reference plasmids, respectively. However, the single accessory regions in these two plasmids were different from their reference plasmids, indicating that new recombination and integration events had occurred in K432. Conclusions: This study provides a comprehensive understanding of the genomic characterization of K432 and identified a novel plasmid for IMP transmission. Further investigation and surveillance are warranted for pK432-IMP-type plasmid. While routine monitoring of MDR E. hormaechei strains is necessary in China. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

25 February 2026 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
LZLihe Zhang
Lihe Zhang
YLYongjuan Li
Yongjuan Li
YBYuhang Bao
Yuhang Bao
JFJie Feng
Jie Feng
RCRunyu Chen
Runyu Chen
WWWu Wang
Wu Wang

1 April 2026 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
ZJZhouguang Jiao
Zhouguang Jiao
HYHaikuan Yu
Haikuan Yu
XLXuekong Li
Xuekong Li
XCXiaoqing Chen
Xiaoqing Chen
FJFangfang Jiao
Fangfang Jiao
XLXinhua Luo
Xinhua Luo
Purpose: Xuebijing (XBJ) injection is a traditional Chinese medicine (TCM) injection prepared using modern pharmaceutical techniques. Approved as a State Category II New Drug for sepsis, XBJ has demonstrated significant clinical efficacy in China. However, the bioactive components of XBJ and the mechanisms underlying its anti-sepsis effects remain to be fully elucidated. This study aimed to elucidate the regulatory network among herbs, compounds, genes, and signaling pathways. Methods: We conducted a network pharmacology analysis by integrating published RNA-sequencing data from the BioProject database and experimental evidence from 27 relevant studies identified in PubMed. And the anti-sepsis effects of XBJ and its main component, Hydroxysafflor Yellow A, were validated in a CLP-induced murine model. Results: Our results demonstrate that XBJ modulates 21 target genes through at least 18 of its bioactive compounds (e.g. Quercetin, Kaempferol). The majority of these genes, including IL6, TNF, and HMGB1, were down-regulated after XBJ treatment. Using a cecal ligation and puncture (CLP)-induced murine sepsis model, we demonstrated that by 24 hours post-operation, the survival rate in the XBJ-treated group was twice that of the PBS-treated group (66.7% vs. 33.3%). Finally, a comprehensive herb-compound-gene-pathway regulatory network was established to illustrate the potential mechanisms of action. Conclusion: In summary, this study reveals that XBJ may alleviate sepsis by modulating target genes via its compounds, primarily through anti-inflammatory and antioxidant pathways. This study provides a systematic elucidation of XBJ’s anti-sepsis mechanism, and the research strategy established here offers a valuable framework for investigating the mechanisms of other complex traditional Chinese medicine formulae. The infographic illustrates the analysis of Xuebijing, starting with databases TTD, TCMIP, CTD, TCMSP leading to target genes of sepsis and Xuebijing-containing compounds. A Venn diagram shows the intersection of XBJ and SEPSIS with 63 common elements. Network pharmacology is depicted with connections between compounds like Quercetin and genes such as MAPK3, PTGS2 and NFKBIA. Published reports are shown with a bubble chart indicating various genes and methods. Molecular docking images are displayed, followed by a diagram linking herbs, compounds, genes and pathways, including the Toll-like receptor signaling pathway and HIF-1 signaling pathway.Schematic diagram of research strategy using network pharmacology, molecular docking, and literature review to decipher Xuebijing injection’s anti-sepsis mechanism.